おすすめコンテンツ

BCGが読む経営の論点2022

アフターコロナを見通し、経営をさらに進化させるために何をすべきか。進展する構造変化の本質と企業経営が目指す方向性について、業界を問わず必須のポイントを提示したうえで、9つの業界の論点をより具体的に示します。

BCGが読む経営の論点2021

コロナ禍の下で加速する社会・経済や個人生活の構造変化に対応し、ビジネスをいかに進化させるか。構造変化をチャンスとするための経営変革の4つの方向性を提示し、12のテーマについて論じます。

実践 BCG流 病院経営――バリューベース・ヘルスケア時代の病院経営

さまざまな医療機関への経営改善支援の経験を基に、医療の質と生産性をともに高めるための考え方と実践的手法について解説します。経営層と現場が一体となった経営改善活動の推進に向け明日から取り組める打ち手が盛り込まれています。

BCG流　病院経営戦略: DPC時代の医療機関経営

日本赤十字社の協力の下、医療現場の経営改善に向けて行った実証的研究を基に、医療の質と生産性を向上させる病院経営戦略の考え方と実践的手法について解説します。

Biopharma

Adopting AI in Drug Discovery

Delivering on the promise requires action on five strategic and operational tracks.

Biopharma Carve-Outs Are Tricky. Here’s How to Get Them Right.

Through carve-outs, companies can create value, streamline portfolios, and reduce complexity. But the ultimate success of a deal hinges on focused, proactive execution.

How Biopharma Is Personalizing Physician Engagement

Powerful new models are in the works, but effective implementation depends on building the right capabilities and enablers.

How the Power of People and Technology Can Build a New Biopharma Business Model

By transforming their commercial operating model, biopharma companies can better engage with health care professionals and patients.

Six Steps to Embed Digital and Analytics in Biopharma Launches

These essential actions weave digital capabilities into each phase of the launch journey.

Doctors’ Changing Expectations of Pharma Are Here to Stay

BCG’s latest survey on the impact of COVID-19 shows which changes in how doctors engage with the pharma industry will last beyond the pandemic.

Five Lessons from the Pandemic for Health Care Systems

Organizations must build on the momentum from their response to the crisis, delivering better care at lower overall cost and becoming more resilient to future disruptions.

Read more

Health Care Payers, Providers, Systems, and Services

In a Crowded Medicare Advantage Market, Know Thy Customer

As competition grows, plans need to win their members’ trust—and their renewal—every year. Here’s how to do it.

Designing the Digital Health Care Systems That People Deserve

The transformation agenda for health care is government-led, tailored to your country's capabilities, and focused on better outcomes. Use this domains-and-roles framework to set your health care systems on track.

Health Care’s New Reality Is Dynamic, Digital—and Here to Stay

What challenges does the future hold for a fast-evolving sector that has undergone decades of change in the past 18 months?

Shooting for the Stars in Medicare Advantage

For health insurance payers, success in Medicare Advantage depends on the stars.

Medical Devices and Technology

Why Ottobock Leads with “Social” in ESG: An Interview with CEO Philipp Schulte-Noelle

A global leader in prostheses, Ottobock set out to also become the ESG leader in its field. The key: measuring the socioeconomic benefit of its products.

Monitoring Patient Health from Hospital to Home

When patients move through hospital units—and eventually are discharged—their vital information doesn’t follow. But smarter solutions can track patient data across settings.

For Cutting-Edge Innovations, the US Pulls Ahead of the EU in Medtech Regulation

A sea change is underway in how companies win regulatory approval for new health care products—particularly in the use of digital technology—and which markets they prioritize.

Planning for the Unpredictable in Health Care Supply Chains

As the current crisis demonstrates, biopharma and medtech companies need to safeguard their networks against unanticipated disruptions. Here’s how.

The Rise of the Next Generation of Medtech “Milkmen”

A next-generation commercial model is needed fast. Those who adopt it quickly will be rewarded handsomely.

Global Health

BCG Executive Perspectives: How to End the Global Pandemic in 2022

BCG Executive Perspectives offer insights on global topics that matter most to leaders in the public and private sectors. Our latest edition explores the evolving landscape of business and leisure travel, examining how companies within and beyond the industry can adapt to new trends.

Reimagining Global Health After the Coronavirus

What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?

Play Video

What It Takes to Crush a Pandemic

BCG Managing Director & Partner Johanna Benesty looks at barriers to "equitable access"—making sure COVID-19 therapeutics are available to all—while sharing a creative approach to vaccine research and development.

• Anticipating the Spread of COVID-19 with Scenario Planning

  BCG’s scenario-planning tool, PLAN, helps you explore the potential impact of COVID-19 in the United States at a region, state, and county level.
• BD’s Vincent Forlenza on Transforming in a Rapidly Changing Industry

  Vincent Forlenza, CEO of BD, has navigated multibillion-dollar acquisitions while driving a full-scale organizational transformation. BD’s success, amid enormous change, hinges on its purpose-driven culture.
• Karalee Close on The Digital Opportunity in Healthcare

  Using digital to harness the next generation of science and the exponential growth of health care data.
• Accelerating Drug Development Today

  Sit in on a conversation with BCG pharma leaders as they discuss advancing drug development with new tools, real-world data, digitization, and collaboration across cross-functional teams.
• Using Big Data to Measure Health Care Outcomes

  According to BCG's Sanjay Saxena, the opportunity for using big data and analytics in measuring outcomes is huge. But the trick for payers and providers will be understanding the data—and knowing which questions to ask about it.
• Jon Kaplan on Health Care Payers

  BCG’s Jon Kaplan explains how health care payers can provide the strongest portfolio of product offerings and best service in today’s marketplace.